High-Sensitivity Troponin: A Review on Characteristics, Assessment, and Clinical Implications.
Journal
Disease markers
ISSN: 1875-8630
Titre abrégé: Dis Markers
Pays: United States
ID NLM: 8604127
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
11
2021
revised:
17
02
2022
accepted:
22
02
2022
entrez:
4
4
2022
pubmed:
5
4
2022
medline:
7
4
2022
Statut:
epublish
Résumé
The use of high-sensitivity cardiac troponin (hs-cTn) assays has become part of the daily practice in most of the laboratories worldwide in the initial evaluation of the typical chest pain. Due to their early surge, the use of hs-cTn may reduce the time needed to recognise myocardial infarctions (MI), which is vital for the patients presenting in the emergency departments for chest pain. The latest European Society of Cardiology Guidelines did not only recognise their central role in the diagnosis algorithm but also recommended their use for rapid rule-in/rule-out of MI. High-sensitivity cardiac troponins are also powerful prognostic markers for long-term events and mortality, not only in a wide spectrum of other cardiovascular diseases (CVD) but also in several non-CVD pathologies. Moreover, these biomarkers became a powerful tool in special populations, such as paediatric patients and, most recently, COVID-19 patients. Although highly investigated, the assessment and interpretation of the hs-cTn changes are still challenging in the patients with basal elevation such as CKD or critically ill patients. Moreover, there are still various analytical characteristics not completely understood, such as circadian or sex variability, with major clinical implications. In this context, the present review focuses on summarizing the most recent research in the current use of hs-cTn, with a main consideration for its role in the diagnosis of MI but also its prognostic value. We have also carefully selected the most important studies regarding the challenges faced by clinicians from different specialties in the correct interpretation of this biomarker. Moreover, future perspectives have been proposed and analysed, as more research and cross-disciplinary collaboration are necessary to improve their performance.
Identifiants
pubmed: 35371340
doi: 10.1155/2022/9713326
pmc: PMC8965602
doi:
Substances chimiques
Biomarkers
0
Troponin
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
9713326Informations de copyright
Copyright © 2022 Diana Raluca Lazar et al.
Déclaration de conflit d'intérêts
All authors declare that they have no conflict of interest.
Références
J Am Coll Cardiol. 2014 Apr 15;63(14):1441-8
pubmed: 24530665
Clin Cardiol. 2020 Apr;43(4):338-345
pubmed: 31851767
Cardiol J. 2017;24(2):139-150
pubmed: 28281735
J Am Soc Nephrol. 2018 Feb;29(2):636-643
pubmed: 29079658
J Clin Invest. 1955 Jan;34(1):126-31
pubmed: 13221663
Eur J Heart Fail. 2021 Sep;23(9):1529-1538
pubmed: 34053177
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
Am J Med. 2018 Mar;131(3):284-292.e1
pubmed: 29106977
Clin Biochem Rev. 2008 Aug;29 Suppl 1:S49-52
pubmed: 18852857
J Am Coll Cardiol. 2013 Jan 15;61(2):187-95
pubmed: 23219305
Vasc Health Risk Manag. 2021 Jun 03;17:299-316
pubmed: 34113117
Clin Chim Acta. 2018 Apr;479:166-170
pubmed: 29366835
Oral Dis. 2013 Mar;19(2):180-4
pubmed: 22834943
Circulation. 2018 Jan 30;137(5):425-435
pubmed: 28978551
Biomolecules. 2019 Sep 09;9(9):
pubmed: 31505902
J Clin Med. 2020 Nov 10;9(11):
pubmed: 33182841
Circulation. 2019 Jun 11;139(24):2754-2764
pubmed: 31014085
Clin Chem. 2012 Jan;58(1):54-61
pubmed: 21965555
J Cardiol. 2018 Apr;71(4):389-393
pubmed: 29108668
Eur Heart J. 2010 Aug;31(15):1836-44
pubmed: 20584774
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
Scand J Clin Lab Invest. 1985 Sep;45(5):413-20
pubmed: 3898341
Ann Intern Med. 2014 Oct 7;161(7):502-12
pubmed: 25111593
Eur Heart J. 2019 Jan 14;40(3):237-269
pubmed: 30165617
Dis Markers. 2021 Jan 6;2021:8828410
pubmed: 33505537
Pflugers Arch. 2008 Mar;455(6):979-86
pubmed: 17909848
Intern Emerg Med. 2017 Mar;12(2):147-155
pubmed: 28188579
JACC Heart Fail. 2015 Jun;3(6):445-455
pubmed: 25982111
J Am Heart Assoc. 2017 Dec 23;6(12):
pubmed: 29275366
J Am Coll Cardiol. 2009 Jun 30;54(1):60-8
pubmed: 19555842
Science. 2009 Apr 3;324(5923):98-102
pubmed: 19342590
Am J Emerg Med. 2011 Jul;29(6):632-8
pubmed: 20627219
J Am Coll Cardiol. 2013 Oct 1;62(14):1231-1238
pubmed: 23933541
J Am Heart Assoc. 2014 Jan 27;3(1):e000403
pubmed: 24470520
J Circ Biomark. 2016 Mar 16;5:6
pubmed: 28936254
N Engl J Med. 1996 Oct 31;335(18):1333-41
pubmed: 8857016
Am J Cardiol. 2020 Nov 15;135:150-153
pubmed: 32861733
Ann Clin Biochem. 2017 Jan;54(1):149-157
pubmed: 27170025
Rev Med Virol. 2021 Jan;31(1):1-10
pubmed: 32845042
J Am Coll Cardiol. 2017 Aug 1;70(5):558-568
pubmed: 28750699
Clin Chem. 2018 Jul;64(7):1104-1112
pubmed: 29632125
J Am Heart Assoc. 2019 Nov 5;8(21):e013091
pubmed: 31662068
Circulation. 2019 Nov 5;140(19):1543-1556
pubmed: 31478763
Cardiovasc Ther. 2019 Feb 5;2019:9546931
pubmed: 31772621
J Clin Med. 2021 Aug 17;10(16):
pubmed: 34441933
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
Clin Chim Acta. 2016 Jul 1;458:68-71
pubmed: 27118089
Eur Heart J. 2016 May 21;37(20):1582-90
pubmed: 26920728
JAMA Cardiol. 2020 Nov 1;5(11):1274-1280
pubmed: 32845276
Acta Paediatr. 2007 Feb;96(2):181-4
pubmed: 17429901
Clin Chem. 1996 Sep;42(9):1454-9
pubmed: 8787704
Prog Biophys Mol Biol. 2020 Nov;157:54-75
pubmed: 32188566
Crit Rev Clin Lab Sci. 2017 May;54(3):143-172
pubmed: 28457177
Clin Chim Acta. 2010 Mar;411(5-6):318-23
pubmed: 20036224
Cardiol J. 2020;27(4):376-383
pubmed: 30338843
Med Clin (Barc). 2021 Sep 24;157(6):274-280
pubmed: 33846001
JAMA Cardiol. 2016 Nov 1;1(8):912-920
pubmed: 27653005
Am Heart J. 2014 Sep;168(3):317-324.e1
pubmed: 25173543
Am Heart J. 2006 Jul;152(1):118-25
pubmed: 16824840
Ther Adv Cardiovasc Dis. 2013 Feb;7(1):45-6
pubmed: 23393062
Clin Chem Lab Med. 1999 Nov-Dec;37(11-12):1097-106
pubmed: 10726818
Clin Chim Acta. 2020 Dec;511:75-80
pubmed: 33010244
Pediatr Cardiol. 2012 Feb;33(2):337-42
pubmed: 22089143
Eur Heart J. 2014 Feb;35(6):365-75
pubmed: 23821402
AIDS. 2013 Apr 24;27(7):1099-108
pubmed: 23211773
J Am Coll Cardiol. 2012 Dec 11;60(23):2427-63
pubmed: 23154053
Rev Cardiovasc Med. 2020 Jun 30;21(2):191-203
pubmed: 32706208
J Am Coll Cardiol. 2000 Sep;36(3):959-69
pubmed: 10987628
Circulation. 2015 Jun 9;131(23):2041-50
pubmed: 25948542
Circulation. 2001 Apr 24;103(16):2035-7
pubmed: 11319190
J BUON. 2018 Dec;23(7):122-131
pubmed: 30722121
J Am Heart Assoc. 2019 Oct;8(19):e013551
pubmed: 31547767
J Int Med Res. 2019 Jul;47(7):3234-3242
pubmed: 31189368